Home
>
US Stocks
>
Cardiff Oncology Inc
Cardiff Oncology Inc
CRDF

Cardiff Oncology Inc

$6.26.2%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.34
Today Low/High
6.2 / 6.36
52 Week Low/High
$4.5 / $25.5
Market Cap
$224.26M

Company Details

Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Its goal is to overcome resistance, improve response to treatment and increase overall survival. The company is developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical development programs incorporate tumor genomics and biomarker technology to enable assessment of patient response to treatment. Cardiff has three clinical programs that have demonstrated the safety and efficacy of onvansertib: a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin® (bevacizumab) in KRAS-mutated metastatic colorectal cancer (mCRC); a Phase 2 study of onvansertib in combination with Zytiga® (abiraterone)/prednisone in metastatic castration-resistant prostate cancer (mCRPC); and a Phase 2 study of onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia (AML). A new Phase 2 trial of onvansertib in combination with nanoliposomal irinotecan, leucovorin and fluorouracil for the second-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDAC) is planned for initiation in the first half of 2021.
Organisation
Cardiff Oncology Inc
Headquaters
San Diego, California, US
Employees
12
Industry
Health Services
CEO
Mark Erlander

Discover more

Frequently Asked Questions

What is Cardiff Oncology Inc share price today

Can Indians buy Cardiff Oncology Inc shares?

How can I buy Cardiff Oncology Inc shares from India?

Can Fractional shares of Cardiff Oncology Inc be purchased?

What are the documents required to start investing in Cardiff Oncology Inc stocks?

We are a SEBI registered investement advisor